![Models for Biomedical Innovation and Commercialization](/sites/default/files/styles/search_thumbnail/public/Biomedical-Lab-FINAL-TEXT-ENG_COVER_0.jpg?itok=JXRSeCFZ)
Models for Biomedical Innovation and Commercialization
![Financing the Control of Tuberculosis](/sites/default/files/styles/search_thumbnail/public/Financing%20the%20Control%20of%20Tuberculosis_cover_0.jpg?itok=wjIPIsjQ)
Financing the Control of Tuberculosis
![Policy and Californias Economy (PACE) Briefing Series: Removing Barriers to Small Business Lending](/sites/default/files/styles/search_thumbnail/public/reports-cover/Thumbnail-PACE-Briefing-Series_2.jpg?itok=GSa8x1OA)
Policy and Californias Economy (PACE) Briefing Series: Removing Barriers to Small Business Lending
![Comments_on_the_Department_of_the_Treasury_TREAS_Notice.pdf](/sites/default/files/styles/search_thumbnail/public/Comments%20on%20the%20Department%20of%20the%20Treasury%20%28TREAS%29%20Notice_cover_0.jpg?itok=AQg8rU1u)
Comments_on_the_Department_of_the_Treasury_TREAS_Notice.pdf
![Walking the Talk: Investing in the Future of Black Banks, Entrepreneurship, and Opportunity](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Walking the Talk: Investing in the Future of Black Banks, Entrepreneurship, and Opportunity
![Ep. 123: Priorities, with Anheuser-Busch’s Michel Doukeris](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Ep. 123: Priorities, with Anheuser-Busch’s Michel Doukeris
![FinTech in Focus - January 18, 2019](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
FinTech in Focus - January 18, 2019
![FinTech in Focus - November 21, 2018](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
FinTech in Focus - November 21, 2018
![FinTech in Focus - May 20, 2019](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
FinTech in Focus - May 20, 2019
![Non-adherence in health care: Are patients or policy makers ill-informed?](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Non-adherence in health care: Are patients or policy makers ill-informed?
![Who Gains More From Medical Innovation: Patients Or Drug Manufacturers?](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Who Gains More From Medical Innovation: Patients Or Drug Manufacturers?
![Building Partnerships to Combat the Opioid Crisis](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)